In a significant step forward in the fight against cancer, G. Kuppuswamy Naidu Memorial Hospital inaugurated its advanced treatment machine- Varian Truebeam HyperArc linear accelerator, with enhanced Surface Guided Radiation Therapy (SGRT), on 9th April 2025.

The facility was launched at the Valavadi Narayanasamy Cancer Centre (VNCC) of the hospital.

The equipment was unveiled by Pavankumar Giriyappanavar, District Collector, Coimbatore, in the presence of Dr. Ragupathy Veluswamy, CEO of the Hospital. The event was attended by leading oncologists and hospital staff, with Dr. Karthiga Sivaprakasam, Chief of Radiation Oncology at GKNMH.

To be noted, this facility, with enhanced Surface Guided Radiation Therapy, is the first of its kind in South India.

This advanced system, featuring IDENTIFY, the first of its kind in South India, uses sophisticated tracking technology to monitor and adjust patient movement in real time. This ensures both treatment accuracy and patient comfort, marking a new era in cancer patients being treated in Coimbatore and surrounding areas.

The Truebeam linear accelerator with SGRT represents a major advancement in cancer care, offering safer, more precise, and comfortable treatments. It utilises cameras and a projector to continuously track the patient’s surface during treatment, allowing for real-time monitoring of position and movement.

This ensures that radiation is delivered with pinpoint accuracy, reducing the damage to surrounding healthy tissues.

Additionally, the system can automatically adjust for small movements, such as breathing, to maintain precise targeting throughout the treatment. Patients also benefit from increased comfort as the technology eliminates the need for uncomfortable skin markings or positioning devices. Furthermore, the system enables personalized treatment plans, tailored to meet each patient’s unique needs.

 

Varian Truebeam linear accelerator

  • Precision and accuracy
  • Personalised treatment plan
  • Improved patient comfort and safety
  • Real-time tumour tracking and monitoring